GRIFOLS | GRF - Current Assets


GRIFOLS reported EUR5.07B in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Alcon AG USD 6.45B 116M Dec/2025
Almirall EUR 713.98M 69K Dec/2025
Amadeus IT EUR 2.48B 47.2M Dec/2025
Amarin USD 649.88M 21.55M Dec/2025
argenx SE USD 5.83B 946.64M Jun/2025
AstraZeneca USD 28.72B 1.22B Dec/2025
Bayer EUR 32.91B 30M Dec/2025
Cie Automotive EUR 1.8B 6.22M Dec/2025
Demant DKK 10.08B 128M Dec/2025
Ence Energia y Celulosa EUR 387.33M 51.77M Dec/2025
Essilor EUR 12.01B 981M Dec/2025
Ferrovial EUR 7.31B 1.67B Dec/2025
Fresenius EUR 12.06B 1.18B Sep/2025
Fresenius Medical Care EUR 7.9B 74M Dec/2025
Galapagos EUR 3.08B 82.56M Dec/2025
Genmab DKK 2.88B 1.59B Dec/2025
GlaxoSmithKline GBP 17.51B 332M Dec/2025
GRIFOLS EUR 5.07B 274.77M Dec/2025
Hikma Pharmaceutical USD 2.64B 86M Dec/2025
Inditex EUR 15.69B 1.79B Dec/2025
Merck EUR 13.23B 354M Dec/2025
Novartis USD 30.46B 2.26B Dec/2025
Philips EUR 9.93B 654M Dec/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Sanofi EUR 30.95B 3.09B Dec/2025
Smith & Nephew USD 4.63B 169M Dec/2025
UCB EUR 6.05B 733M Dec/2025
Viscofan EUR 781.5M 34.71M Dec/2025